Depression and Anxiety Trial, Recruiting NCT07338292 Sponsor: Istituto Oncologico Veneto IRCCS Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07338292
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who are scheduled to have one of the specific procedures included in this study for the very first time
  • People scheduled for a minor, low-invasiveness urological procedure that may involve a small needle or tube for access — such as a circumcision, prostate biopsy, or flexible cystoscopy (a camera examination of the bladder)
  • People who are able to understand instructions and fill out study questionnaires
  • People who have signed a form giving their consent to take part in the study

Who may not be able to join:

  • People who have a medical reason that makes the planned urological procedure unsafe for them — for example, an active urinary tract infection or an unusual physical structure in the urinary passage
  • People who have recently had certain urological procedures, such as stretching of the urinary passage, a bladder biopsy, or the insertion or removal of an internal tube used to drain the kidney
  • People who have a medical condition that makes virtual reality (VR) headset use unsafe, such as uncontrolled light-triggered epilepsy, or certain conditions affecting the nervous system, eyes, or ears
  • People living with severe mental health conditions or serious heart or blood vessel disease that could interfere with taking part in the study
  • People who have had a bad reaction to using virtual reality in the past
  • People who have taken pain-relieving medication in the 24 hours before their procedure
  • People taking medications that affect awareness or mental clarity in a way that could prevent them from completing psychological questionnaires
  • People with significant difficulties communicating or with serious hearing loss that would prevent them from completing the study questionnaires

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0423-421321

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Oncologico Veneto IRCCS
Registry
ClinicalTrials.gov
Start date
17 December 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Anxiety reduction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov